References
- 1982 Industrial Pharmaceutical R & D Symposium on “Transdermal Controlled Release Medication”. Jan., 14 & 151982. Rutgers University, College of Pharmacy, Piscataway, New Jersey 1983; 9: 497–744, Drug Develop. & Ind. Pharm.
- Scheuplein R. J., Blank I. H. Permeability of the Skin. Physio. Rev. 1971; 51: 702–746
- Berenson G. S., Burch G. E. Studies of diffusion of water through dead human skin: Effect of different environment states and of chemical alterations of epidermis. Am. J. Trop. Med. 1951; 31: 842–853
- Yu C. D., Fox J. L., Ho N. F. H., Higuchi W. I. Physical model evaluation of topical prodrug delivery ‐ Simultaneous transport and bioconversion of Vidarabine‐ 5′‐ Valerate II: Parameter determinations. J. Pharm. Sci. 1979; 68: 1347–1357
- Franz T. J. The finite dose technique as a valid in‐vitro model for the study of percutaneous absorption in man. Curr. Prob. Dermatol. 1978; 7: 58–68
- Keshary P. R., Chien Y. W. Mechanism of Transdermal Controlled Nitroglycerin Administration (I): Development of a Finite‐dosing Skin Permeation System. Drug Develop. & Ind. Pharm. 1984; 10, [In press]
- Behl C. R., Linn E. E., Flynn G. L., Pierson C. L., Higuchi W. I., Ho N. F. H. Permeation of Skin and Eschar by Antiseptics I: Baseline Studies with Phenol. J. Pharm. Sci. 1983; 72: 391–396
- Keshary P. R., Huang Y. C., Chien Y. W. Transdermal Controlled Administration of Nitroglycerin : (I) Skin Permeability of Nitroglycerin from Controlled Release Formulations. J. Pharm. Sci., (submitted for publication)
- Yie Chien W. Logics of Transdermal Controlled Drug Administration. Drug Develop. & Ind. Pharm. 1983; 9: 497–520